Myung-Hwa Kim

Title: Myung-Hwa Kim: Innovator in Pharmaceutical Composition

Introduction

Myung-Hwa Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in improving the solubility of tricyclic derivatives. With a total of five patents to his name, Kim's work is recognized for its potential impact on various medical conditions.

Latest Patents

One of Kim's latest patents focuses on a pharmaceutical composition that enhances the solubility of partially soluble tricyclic derivatives. This innovative composition includes lipid nanoparticles composed of phospholipids, cholesterol, and ionic lipids. The formulation allows for high concentrations of the tricyclic derivative without the use of harmful solubilization aids. It maintains improved solubility even when water is added for injection purposes and demonstrates stability over extended storage periods. Another significant patent involves a novel tricyclic derivative that exhibits efficient inhibitory activity against poly(ADP-ribose) polymerases (PARP). This derivative is particularly useful in preventing or treating diseases associated with excessive PARP activity, including neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic nephropathy, inflammatory diseases, osteoporosis, and cancer.

Career Highlights

Myung-Hwa Kim is currently associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approaches to pharmaceutical formulations.

Collaborations

Kim has collaborated with notable colleagues, including Kwang-Woo Chun and In-Hae Ye, who contribute to his research endeavors.

Conclusion

Myung-Hwa Kim's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work on tricyclic derivatives and lipid nanoparticles showcases the potential for improved treatments for various medical conditions.